NCT04196387

Brief Summary

Antibiotics are medicines used to avoid and treat bacterial infections. Antibiotic resistance is increasing to dangerous level globally.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2019

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 7, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 12, 2019

Completed
Last Updated

May 1, 2023

Status Verified

April 1, 2023

Enrollment Period

2.3 years

First QC Date

December 7, 2019

Last Update Submit

April 28, 2023

Conditions

Antibiotic Reaction

Keywords

antibiotics, urine, resistance

Outcome Measures

Primary Outcomes (1)

  • urine culture results

    type of bacterial strain was isolated

    3 years

Interventions

urine cultureDIAGNOSTIC_TEST

urine culture and antibiotic susceptibility test

Eligibility Criteria

Age6 Months - 88 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with dysurea

You may qualify if:

  • patients with UTI
  • patients with dysuria
  • patients with loin pain

You may not qualify if:

  • patients with surgery
  • patients with cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof Dr Batool Mutar Mahdi

Study Record Dates

First Submitted

December 7, 2019

First Posted

December 12, 2019

Study Start

January 1, 2017

Primary Completion

April 30, 2019

Study Completion

April 30, 2019

Last Updated

May 1, 2023

Record last verified: 2023-04